» Articles » PMID: 18585836

Kidney Function and Cognitive Impairment in US Adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Overview
Journal Am J Kidney Dis
Specialty Nephrology
Date 2008 Jul 1
PMID 18585836
Citations 196
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The association between kidney function and cognitive impairment has not been assessed in a national sample with a wide spectrum of kidney disease severity.

Study Design: Cross-sectional.

Setting & Participants: 23,405 participants (mean age, 64.9 +/- 9.6 years) with baseline measurements of creatinine and cognitive function participating in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study, a study of stroke risk factors in a large national sample.

Predictor: Estimated glomerular filtration rate (eGFR).

Outcome: Cognitive impairment.

Measurements: Chronic kidney disease (CKD) was defined as eGFR less than 60 mL/min/1.73 m(2). Kidney function was analyzed in 10-mL/min/1.73 m(2) increments in those with CKD, and in exploratory analyses, across the range of kidney function. Cognitive function was assessed using the 6-Item Screener, and participants with a score of 4 or less were considered to have cognitive impairment.

Results: CKD was associated with an increased prevalence of cognitive impairment independent of confounding factors (odds ratio, 1.23; 95% confidence interval, 1.06 to 1.43). In patients with CKD, each 10-mL/min/1.73 m(2) decrease in eGFR less than 60 mL/min/1.73 m(2) was associated with an 11% increased prevalence of impairment (odds ratio, 1.11; 95% confidence interval, 1.04 to 1.19). Exploratory analyses showed a nonlinear association between eGFR and prevalence of cognitive impairment, with a significant increased prevalence of impairment in those with eGFR less than 50 and 100 mL/min/1.73 m(2) or greater.

Limitations: Longitudinal measures of cognitive function were not available.

Conclusions: In US adults, lower levels of kidney function are associated with an increased prevalence of cognitive impairment. The prevalence of impairment appears to increase early in the course of kidney disease; therefore, screening for impairment should be considered in all adults with CKD.

Citing Articles

Kidney function and cognitive impairment: a systematic review and meta-analysis.

Pei X, Bakerally N, Wang Z, Bo Y, Ma Y, Yong Z Ren Fail. 2025; 47(1):2463565.

PMID: 40037396 PMC: 11881663. DOI: 10.1080/0886022X.2025.2463565.


Measuring Hemoglobin A1C with Frozen Packed Cell and Frozen Whole Blood Samples in an Epidemiologic Study: The Reasons for Geographic and Racial Differences in Stroke Study.

Kamin Mukaz D, Tison S, Long D, Carson A, Hunt K, Judd S J Clin Lab Anal. 2025; 39(4):e25121.

PMID: 39921333 PMC: 11848213. DOI: 10.1002/jcla.25121.


Current Status of the Cognitive Impairment in Chronic Kidney Disease.

Otobe Y Phys Ther Res. 2025; 27(3):115-120.

PMID: 39866390 PMC: 11756563. DOI: 10.1298/ptr.R0033.


Kidney Function, Cognitive Impairment, and Trajectories: A Longitudinal Biracial Study.

Cheung K, Arce Renteria M, Callas P, Kurella Tamura M, Gutierrez O, Cushman M J Gen Intern Med. 2025; .

PMID: 39843671 DOI: 10.1007/s11606-025-09366-0.


Analysis of Levels of Vitamin D, Beta-Amyloid 42, Indoxyl Sulfate, and Serum Parathyroid Hormone in Hemodialysis Patients with Cognitive Impairment.

Syafrita Y, Harun H, Susanti R, Indra S Innov Clin Neurosci. 2025; 21(10):44-47.

PMID: 39790902 PMC: 11709437.


References
1.
Kurella M, Yaffe K, Shlipak M, Wenger N, Chertow G . Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis. 2005; 45(1):66-76. DOI: 10.1053/j.ajkd.2004.08.044. View

2.
Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-70. DOI: 10.7326/0003-4819-130-6-199903160-00002. View

3.
Yaffe K, Lindquist K, Penninx B, Simonsick E, Pahor M, Kritchevsky S . Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003; 61(1):76-80. DOI: 10.1212/01.wnl.0000073620.42047.d7. View

4.
Seshadri S, Beiser A, Selhub J, Jacques P, Rosenberg I, DAgostino R . Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002; 346(7):476-83. DOI: 10.1056/NEJMoa011613. View

5.
Stevens L, Coresh J, Greene T, Levey A . Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354(23):2473-83. DOI: 10.1056/NEJMra054415. View